01 November 1999
Med Sci Monit 1999; 5(6): BR1081-1089 :: ID: 503101
The tetanus toxin (Tetx) administered intracerebroventricularly (i.c.v.) or intraperitoneally (i.p.) caused the death of 50% of experimental mice (LD50,) at a dose of 18.0 (11.5-28.2) MLDs or 11.0 (8.3-14.6) MLDs/kg each. The minimal lethal dose (MLD) is defined as the lowest dose of Tetx required to kill a 20.0 g albino mouse within 96 hours following i.p. treatment . Tetx increased the convulsive threshold of the electrical current and diminished particular chemical convulsant potencies. At the same time Tetx increased the protection given by a number of anti-epileptics during maximal electroshock treatment (MES). There were no marked γ-aminobutyric acid (GABA) concentration and total L-glutamic acid decarboxylase activity changes(GAD) in whole-brain homogenates accompanying Tetx treatment. These results suggest the preponderance of inhibitory over excitatory transmission probably due to Tetx action at the neuronal level. Tetx that penetrates into the central nervous system (CNS) following an i.p. injection evokes changes similar to those noted during Tetx administration into the lateral ventricle. Thus, both routes of adminstration demonstrate comparable predictive values in describing Tetx-induced changes during convulsive thresholds. Pertussis toxins (0.5 µg/animal, i.c.v., 120 h prior to testing), enhanced the chemical convulsants potency and decreased the carbamazepine protection during MES. It remained without marked influence upon the action of diphenylhydantoin and diazepam. These observations suggest that the enhanced sensitivity towards a number of chemical convulsants, irrespective of their action possibly results from a functional suppression of the inhibitory transmission at receptors coupled with pertussis toxin sensitive G proteins, rather than due to direct action on the G protein linked excitatory neurotransmission. The attenuation of carbamazepine efficacy might result in the sum of adenosine receptor antagonist drug properties and transmission suppression at the level of adenosine receptors coupled with G proteins sensitive towards pertussis toxins. Both toxins did not influence the total plasma levels of any anti-epileptic drug. Thus, the observed interactions between Tetx/pertussis toxins and anti-epileptic drugs probably occur at the neuronal level.
Keywords: Mice, Electroshock, Pertussis Toxin, Tetanus Toxin
This Week Editorial
20 September 2021 : EditorialEditorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
Med Sci Monit 2021; 27:e934766
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700